CURTO, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.967
EU - Europa 1.385
AS - Asia 615
AF - Africa 77
SA - Sud America 19
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.074
Nazione #
US - Stati Uniti d'America 3.926
IT - Italia 798
SG - Singapore 231
IN - India 174
SE - Svezia 164
CN - Cina 150
FI - Finlandia 89
TG - Togo 68
DE - Germania 62
UA - Ucraina 47
GB - Regno Unito 45
CA - Canada 37
BG - Bulgaria 35
IE - Irlanda 32
FR - Francia 29
NL - Olanda 19
RU - Federazione Russa 17
ID - Indonesia 15
TW - Taiwan 14
AR - Argentina 13
BE - Belgio 13
RO - Romania 10
CH - Svizzera 9
AU - Australia 7
JP - Giappone 6
ZA - Sudafrica 6
KR - Corea 4
MX - Messico 4
TR - Turchia 4
CL - Cile 3
DK - Danimarca 3
ES - Italia 3
EU - Europa 3
PL - Polonia 3
BR - Brasile 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
IL - Israele 2
IR - Iran 2
MY - Malesia 2
VN - Vietnam 2
A1 - Anonimo 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MU - Mauritius 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
TJ - Tagikistan 1
Totale 6.074
Città #
Fairfield 687
Woodbridge 308
Ashburn 287
Chandler 276
Seattle 260
Cambridge 242
Rome 242
Houston 223
Wilmington 203
Singapore 172
Ann Arbor 138
Princeton 102
San Paolo di Civitate 85
Santa Clara 73
Dearborn 72
Plano 72
Beijing 71
Lomé 68
Lawrence 61
Millbury 59
San Diego 53
New York 39
Milan 38
Helsinki 37
Boston 35
Sofia 35
Dublin 31
Norwalk 30
Fremont 21
Toronto 19
Munich 16
Andover 15
Bremen 15
Jakarta 15
Taipei 14
Brussels 13
Boardman 12
Jacksonville 12
Nanjing 12
Ottawa 12
Pittsburgh 12
Redwood City 12
Federal 11
Naples 11
Bari 10
Florence 10
London 10
Caldogno 9
Des Moines 9
Moscow 9
Phoenix 9
Cagliari 8
Catania 8
Guangzhou 8
Hefei 8
Kunming 7
Padova 7
Pune 6
San Mateo 6
Buffalo 5
Bühl 5
Como 5
Frankfurt am Main 5
Los Angeles 5
Messina 5
Muizenberg 5
Paris 5
Auburn Hills 4
Bloomfield Hills 4
Bracciano 4
Cisterna Di Latina 4
Falkenstein 4
Guelph 4
Lucca 4
Mannheim 4
Menlo Park 4
Perugia 4
Pisa 4
Sezze 4
Tokyo 4
Yellow Springs 4
Acerra 3
Alessandria 3
Bergamo 3
Prato 3
Shanghai 3
Verona 3
Ankara 2
Aversa 2
Avezzano 2
Bath 2
Bern 2
Brisbane 2
Brno 2
Buk-gu 2
Carugate 2
Casorate Primo 2
Chatsworth 2
Chengdu 2
Chennevières-sur-Marne 2
Totale 4.485
Nome #
Variabili psicopatologiche correlate all'abbandono scolastico precoce in un campione di adolescenti help-seeker. 150
Impairment in Social Functioning differentiates youth meeting ultra-high risk for psychosis criteria from other mental health help-seekers. A validation of the Italian version of the Global Functioning: Social and Global Functioning: Role scales 134
Relationship between the rorschach perceptual thinking Index (pti) and the positive and negative syndrome scale (panss) in psychotic patients: a validity study 133
Rimegepant. calcitonin gene-related peptide (CGRP) receptor antagonist, treatment of migraine 123
Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice 123
Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important 122
Xanthurenic Acid Activates mGlu2/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia 121
Serum xanthurenic acid levels. reduced in subjects at ultra high risk for psychosis 112
Altered serum levels of kynurenine metabolites in patients affected by cluster headache 111
Antipsychotic treatment and the Rorschach Perceptual Thinking Index (PTI) in psychotic disorder patients: Effects of treatment 107
Increased total urinary cortisol (tUC) and serum Brain Derived Neurotrophic Factor (BDNF) Ratio in Alzheimer Disease (AD) affected patients 106
Executive functions in obsessive–compulsive disorder. An activation likelihood estimate meta-analysis of fMRI studies 105
Neurocognition in schizophrenia: from prodrome to multi-episode illness. 100
Depressive symptoms, temperament/character, and attention deficit/hyperactivity disorder traits in medical students seeking counseling 100
Altered kynurenine pathway metabolites in serum of chronic migraine patients 97
Self-reported attenuated psychotic-like experiences in help-seeking adolescents and their association with age, functioning and psychopathology 97
Applicazioni cliniche dell'approccio dimensionale alla psicopatologia di personalità: il dominio "Distacco" del questionario PID-5 rappresenta il miglior predittore di scarso funzionamento negli adolescenti con sintomi psichiatrici. 95
The Italian version of the 92-item Prodromal Questionnaire: Concurrent validity with the SIPS and factor analysis in a sample of 258 outpatients aged 11-36years. 93
Choosing the safest acute therapy during chronic migraine prophylactic treatment. pharmacokinetic and pharmacodynamic considerations 92
Pharmacogenetic considerations for migraine therapies 92
Increased serum Dickkopf-1 levels in drug-abusing psychotic patients 91
Interpersonal sensitivity and functioning impairment in youth at ultra-high risk for psychosis 91
Basic symptoms and psychotic symptoms: Their relationships in the at risk mental states, first episode and multi-episode schizophrenia 89
Antidepressant effectiveness of deep Transcranial Magnetic Stimulation (dTMS) in patients with Major Depressive Disorder (MDD) with or without Alcohol Use Disorders (AUDs): A 6-month, open label, follow-up study 89
Efficacy of the “cooperative assessment” diagnostic procedure to early improve acute symptoms in a sample of adolescents with anxiety and mood disorders 88
Validation of the Italian version of interpersonal sensitivity measure (IPSM) in adolescents and young adults 88
Acute, transitional and long-term cluster headache treatment. pharmacokinetic issues 86
Cardiovascular efficacy and safety of bococizumab in high-risk patients 86
Relationship between the Rorschach Perceptual Thinking Index (PTI) and the Structured Interview for Prodromal Symptoms (SIPS) in a sample of helpseeker adolescents 84
Eletriptan in the management of acute migraine. An update on the evidence for efficacy, safety, and consistent response 83
LC-MS/MS simultaneous analysis of allopregnanolone; epiallopregnanolone; pregnanolone; dehydroepiandrosterone and dehydroepiandrosterone 3-sulfate in human plasma 83
Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study 83
How do you choose the appropriate migraine pharmacotherapy for an elderly person? 82
OnabotulinumtoxinA 155 U in medication overuse headache. a two years prospective study 80
Skin Rash Occurring with Olanzapine Pamoate, but not with Oral Olanzapine, in a Male with Juvenile Idiopathic Arthritis 79
The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia 79
Features preceding diagnosis of bipolar versus major depressive disorders 77
A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache. a real-world experience 76
Lasmiditan for the treatment of migraine 76
Anti-CGRP monoclonal antibodies in migraine. current perspectives 75
Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels 72
O066. Kynurenine pathway metabolites in cluster headache 72
A critical evaluation on MOH current treatments 70
null 70
Sudden Death Associated with Complex Treatment of Acute Mania: Case Report and Toxicological Findings 70
Profiling lasmiditan as a treatment option for migraine 68
Temperament and Character in Ultra-High Risk for Psychosis (UHR) compared to non-UHR helpseeking adolescents 67
EFFICACY OF THE “COOPERATIVE ASSESSMENT” DIAGNOSTIC PROCEDURE TO EARLY IMPROVE WORKING ALLIANCE, TRANSFERENCE AND COUNTERTRANFERENCE IN A SAMPLE OF FIRST PSYCHIATRICALLY DIAGNOSED ADOLESCENTS 67
Pharmacological strategies against glucocorticoid-mediated brain damage during chronic disorders 66
Systematic review of clozapine cardiotoxicity 66
Affective Neuroscience Primary Brain Emotional Systems in Ultra-High-Risk (UHR) and non-UHR Adolescent Helpseekers 66
null 63
null 61
The presence of depressive symptoms in comorbidity with Alzheimer's disease does not influence changes in serum brain-derived neurotrophic factor levels in older patients 61
Chronic migraine treatment. from OnabotulinumtoxinA onwards 60
Impact of migraine on fibromyalgia symptoms 59
Interpersonal sensitivity and functioning impairment in the at risk syndrome for psychosis 59
Headache. Cluster headache treatment-RCTs versus real-world evidence 58
Polyamines serum levels in episodic and chronic migraine 58
Diagnostic Efficiency of the Rorschach Perceptual and Thinking Index (PTI) in discriminating Ultra High Risk (UHR) Adolescent helpseekers from non-UHR 57
Atogepant. Calcitonin gene-related peptide (CGRP) receptor antagonist, Preventive treatment of migraine 57
Factors associated with costs of hospitalization of severely mentally Ill patients 56
Psychiatric comorbidity in migraine and chronic headache 55
Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report. 55
EFFICACY OF THE COOPERATIVE ASSESSMENT METHOD (COOPAS) TO IMPROVE THE PSYCHIATRIC CARE OF HELP-SEEKING ADOLESCENTS 54
null 54
Re: Response to Anderson's Letter to the Editor. Comment on: Hemochromatosis and bipolar disorder, Serata et al. (2012) Gen Hosp Psychiatry 34(1)101.e1-101.e3 52
Aumento dei livelli sierici di Dickkopf-1 nei pazienti psicotici che abusano di droghe. 51
Persistent post-traumatic headache and migraine: Pre-clinical comparisons 50
Liberiamo il Futuro: first results of an Italian early detection project. 49
Ubrogepant for the treatment of migraine 48
Tryptophan and kynurenine metabolites: Are they related to depression? 48
Fremanezumab for the preventive treatment of migraine in adults 47
RORSCHACH PERCEPTUAL AND THINKING INDEX (PTI) ASSESSES POSITIVE AND NEGATIVE SYMPTOMS OF PSYCHOSIS IN ACUTE AND CHRONIC PHASE INDEPENDENTLY OF THE PRESENCE OF ANTIPSYCHOTIC TREATMENT. 42
Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-HT2A serotonin receptors in the frontal cortex of living mice. 37
Interaction between 5-HT2A and mGLU2/3 receptor signalling in cortical slices 37
Cluster Headache is Still Lurking in the Shadows 31
School refusal behavior. role of personality styles, social functioning, and psychiatric symptoms in a sample of adolescent help-seekers 30
Circulating BDNF levels in elderly patients with depression, Alzheimer disease (AD), comorbid AD and depression and in healthy age-matched and young subjects. 30
The validity of a clinical impression questionnarie to identify UHR patients 29
Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors 28
La terapia farmacologica della malattia di Alzheimer 27
null 27
Xanthurenic and cinnabarinic acids: two kynurenine metabolites interacting with metabotropic glutamate receptors involved in schizophrenia and ultra-high risk for psychosis states 26
Depressione e malattia di alzheimer nei pazienti anziani con disabilità: un contributo alla confusivita ’ diagnostica 24
Depressione e deficit cognitivo: “Bad Companions” nell’anziano con disabilità 23
null 22
NeuroEndocrine- immunology in orthogeriatric patients: preliminary report on the acute modification of urinanry cortisol and serum BDNF levels in Alzheimer’s disease after osteoporotic hip fracture 21
Unmet needs for migraine 21
Impairment of left ventricular function early in treatment with clozapine. a preliminary study 20
A novel SCL-90-R six-item factor identifies subjects at risk of early adverse outcomes in public mental health settings 18
Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors 15
Risultati preliminari sul cortisolo e il BDNF come marcatori biologici per le funzioni cognitive ed i disturbi neuropsichiatrici degli anziani 15
Dialectical behaviour therapy (DBT) for forensic psychiatric patients: An Italian pilot study 15
Psychotropic Drugs Levels in Seminal Fluid: A New Therapeutic Drug Monitoring Analysis? 11
The Prevention and Treatment of Delirium in Elderly Patients Following Hip Fracture Surgery. 6
Totale 6.399
Categoria #
all - tutte 17.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020999 0 0 0 0 0 192 221 186 179 103 81 37
2020/2021513 64 39 33 34 29 37 11 48 56 80 53 29
2021/20221.021 28 69 89 34 127 54 29 93 63 79 186 170
2022/20231.101 208 283 62 94 118 97 18 83 84 10 32 12
2023/2024634 28 70 26 58 45 112 17 52 25 98 46 57
2024/2025463 36 55 73 95 106 98 0 0 0 0 0 0
Totale 6.399